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Abstract
Background: Older adults and individuals with underlying chronic diseases are at increased risk of developing
influenza-related complications and are target groups for seasonal influenza vaccination in many countries. In
Germany, an annual national information campaign is conducted to increase influenza vaccination uptake in the
target groups. However, data are lacking on knowledge and attitudes toward influenza vaccination among older
adults and those with chronic diseases. The present study aimed to (i) estimate influenza vaccination uptake for the
2012/13 and 2013/14 seasons, (ii) assess knowledge and attitudes about influenza vaccination, and (iii) identify
factors associated with vaccination uptake in two risk groups.
Methods: Between March and June 2014, we conducted a nationwide cross-sectional survey in adults (≥18 years)
living in Germany using computer-assisted telephone interviewing. We calculated weighted vaccination coverage
rates in two at-risk groups. Group 1 comprised participants aged 18–59 years with underlying chronic diseases.
Group 2 comprised participants aged 60+, irrespective of underlying disease. We used univariate and multivariable
logistic regression analyses to identify associations between influenza vaccination uptake and sociodemographic
characteristics, and to evaluate attitudes and knowledge.
Results: In total, 1,519 interviews were conducted. Seasonal influenza vaccination uptake in people with underlying
chronic diseases aged 18–59 years was 24 % in 2012/2013 and 23 % in 2013/2014. In older adults, uptake was 50 %
and 49 % in 2012/13 and 2013/14 respectively. There were considerable vaccination-related knowledge gaps among
respondents. For example, about half of the participants who aged ≥60 years and/or suffered from underlying chronic
diseases believed that influenza vaccination could cause influenza. The most commonly stated reasons for not being
immunized were mistrust of the vaccination (22 %) and the perception that influenza is not dangerous (21 %). For
both groups, vaccination uptake was independently associated with sex, perceived severity of influenza, perceived
vaccination effectiveness, and the perceived likelihood or severity of vaccination side effects. For older adults,
additional factors influencing vaccination uptake were age, underlying chronic diseases, and recent advice through
physician consultation.
Conclusions: Influenza vaccination coverage rates in Germany remain low. Individual perceptions regarding harms
and benefits are crucial in the decision-making process. Communication strategies should focus on improving
understanding and perception of personal risks arising from the disease and the vaccination.
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Background
Older adults and people with underlying chronic diseases
have an increased risk of developing severe influenza and
influenza-related complications [1–3]. Therefore, the
World Health Organization and National Immunization
Technical Advisory Groups in most industrialized coun-
tries recommend seasonal influenza vaccination for these
at-risk groups [4–6].
To reduce influenza-associated morbidity and mortal-
ity, European Union (EU) member states committed to
the goal of attaining vaccination coverage of at least
75 % for older age groups by 2014/15 [7]. However, thus
far, only the Netherlands and the United Kingdom have
achieved the 75 % threshold for older adults, whereas
other European countries, including Germany, are still
below the projected target [8].
To raise awareness about the importance of influenza
vaccination and to increase vaccination uptake, an an-
nual national information campaign is conducted in
Germany. Data on vaccination uptake in different target
groups, and about knowledge of and attitudes toward
vaccination are crucial to this campaign and the progress
towards the EU vaccination coverage goal. As Germany
has no central immunization registry, information on in-
fluenza vaccination coverage is predominantly available
from population-based cross-sectional surveys [9] and
from health assurance claims data [10]. However, data
on attitudes and knowledge about seasonal influenza
and vaccination in specific target groups are limited.
Therefore, we conducted a nationwide cross-sectional
survey in Germany to (i) estimate influenza vaccination
uptake in older adults and in individuals with underlying
chronic diseases for the 2012/13 and 2013/14 seasons,
(ii) assess attitudes toward and knowledge about sea-
sonal influenza and seasonal influenza vaccination and
(iii) identify factors associated with vaccination uptake in
these two at-risk groups.
Methods
Study design and population
We conducted a nationwide cross-sectional survey be-
tween March and June 2014 using computer-assisted
telephone interviewing. Inclusion criteria for participa-
tion were (i) being at least 18 years of age, (ii) German-
speaking, and (iii) having a mobile or landline telephone.
Telephone numbers were randomly generated using
Waksberg’s method [11], adapted by Gabler and Häder
[12] for Germany and provided by the Leibniz Institute
for the Social Sciences (GESIS) in Mannheim, Germany.
People who were reached by landline were selected by
last-birthday-method [13]. For the mobile phone sample,
interviews were conducted with the person who an-
swered the phone. Calls took place Mondays through
Fridays from 9:30 a.m. to 2:30 p.m. and from 3:00 p.m.
to 8:00 p.m., and Saturdays from 10:00 a.m. to 3:00 p.m.
If the number dialed gave a busy signal or rang but
was unanswered, up to 10 further attempts were made
to contact the number. The management of telephone
calls and call-backs was automatically regulated by
the computer-assisted telephone interviewing software
Voxco CC3 (10.3, Montreal, Canada). The interviews
were conducted in German by trained interviewers from
the Robert Koch Institute.
According to a sample size calculation, 760 subjects ≥60 years
were needed to estimate a coverage of 48 % (vaccination
rate in 2009/10 in this age group [14]) with a confidence
interval of 95 % and an error estimate of 5 %. Response
and Cooperation Rates 3 were calculated as defined by
the American Association for Public Opinion Research
(AAPOR) [15].
Questionnaire
We used a structured an pre-tested questionnaire that col-
lected data on (i) behavior, attitudes and knowledge about
seasonal influenza vaccination and influenza disease, (ii)
information behavior concerning influenza immunization,
and (iii) sociodemographic factors. The majority of survey
items had been used in previous studies conducted by the
Robert Koch Institute [9, 16] but were adapted to our
study sample and design. All questions were self-reported
and not validated.
Influenza vaccination uptake in 2012/13 and/or 2013/
14 was defined as having received a flu shot in the re-
spective season. Additionally, information on the influ-
enza vaccination status for each child living in the
respective household of the participant was collected for
the 2013/14 season. To assess influenza and vaccination-
related knowledge, we asked participants to agree/dis-
agree or state “don’t know” to specific statements. We
assumed that a lack of knowledge (don’t know) reflected
a lack of awareness about the importance of obtaining
vaccination; therefore, don’t know was defined as an in-
correct answer.
We used 10-point Likert-scales to assess perceived
probability of acquiring influenza disease and probability
of severe side effects following vaccination (“not likely”
to “very likely”), perceived severity of the influenza dis-
ease and perceived severity of vaccination side effects
(“not serious” to “very serious”) as well as perceived vac-
cination effectiveness (“not effective” to “very effective”).
For sociodemographic factors, we collected data on age,
sex, place of residence, education level, migration back-
ground and chronic illnesses such as diabetes, stroke, car-
diovascular diseases, renal failure, liver diseases, cancer,
chronic neurologic disease, immune deficiency, bronchitis,
or asthma. Migration background was defined as de-
scribed by Schenk et al. based on parents’ country of birth
[17]. A participant was defined as chronically ill if any of
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the above mentioned diseases had been diagnosed by a
physician during their lifetime.
Participants who were ≥60 years of age and/or suffered
from underlying chronic diseases were regarded as at-risk.
Statistical analysis
To control for possible sampling and selection biases,
the sample was weighted to match national general
population parameters. The basic weighting parameters
were derived from the Federal Statistical Office of
Germany for 2011 [18] and included the geographical
region, age, sex, and education. All results are presented
as weighted data unless otherwise stated.
Descriptive statistics were applied to describe sociode-
mographic characteristics, vaccination coverage, reasons
for not being vaccinated, information behavior, and atti-
tude and knowledge characteristics. We used Pearson’s
chi-square test to compare vaccination- and influenza-
related knowledge items between vaccinated and unvac-
cinated at-risk participants. Additionally, we conducted
stratified univariate and multivariable logistic regression
analyses to determine potential associations between
influenza vaccination uptake and sociodemographic
characteristics, attitude and knowledge items. For this
purpose we stratified the study population into two sub-
groups. Group 1 consisted of people aged 18–59 years
with underlying chronic diseases. Group 2 comprised
people aged ≥60 years, irrespective of whether they had
an underlying chronic disease. Odds ratios (OR) and
95 % confidence intervals (CI) were calculated. A p-value
of <0.05 was considered statistically significant. Variables
with a p-value of ≤0.1 in the univariate analysis were en-
tered in the first step of the multivariable analyses. We
then removed non-significant factors (≥0.05) from the
model in a stepwise backward procedure to obtain
the final model. Although they were not significant in
the final model, sex, age and education variables were
included a priori and were not removed. Additionally,
an interaction term (sex#chronic disease) was included
in the final model for older adults. Missing data were
not replaced or imputed. Statistical analyses were per-
formed with StataSE13 (StataCorp LP, College Station,
TX, USA) using complex survey methods.
Ethical considerations and data protection
Participants were informed about study details, including
data protection and privacy issues. Verbal consent was
required for participants to be included in the study.
Telephone numbers were generated randomly and were
deleted directly after the interview. The study was ap-
proved by the German Federal Commissioner for Data
Protection and Freedom of Information. All data were
collected and analyzed anonymously.
Results
Recruitment and sample characteristics
In total, 1,519 participants were interviewed. The Re-
sponse Rate 3 was 16.2 % and the Cooperation Rate 3
was 28.7 %. An overview of the study population charac-
teristics is presented in Table 1. Overall, 55.1 % (95 % CI
51.6–58.5) of the participants were aged ≥60 years and/
or had an underlying chronic disease.
Vaccination coverage
Influenza vaccination status was available for almost all
participants (2012/13: 98.6 %; 2013/14: 99.9 %). Vaccin-
ation rates for the 2012/13 and 2013/14 seasons by sex,
age, underlying chronic disease and residency are pre-
sented in Table 2. Overall, more than 25 % of partici-
pants (at risk and not at risk) were vaccinated against
seasonal influenza. Of those who received the flu shot in
2012/13, 70.8 % (95 % CI 64.8–76.2) were also vacci-
nated the following season. In 2012/13 vaccination up-
take in Group 2 participants (those aged ≥60 years) was
50.0 %, and in 2013/14 uptake was 49.4 %. For those
aged ≥65 years, coverage was 53.1 % in both seasons
Table 1 Characteristics of the study sample, Germany, 2014
Study population %
(95 % CI)a
Sex (n = 1,519)
Male 47.6 (44.2–51.0)
Female 52.5 (49.0–55.8)
Age (n = 1,519)
18–39 years 31.5 (28.3–35.0)
40–59 years 33.1 (29.9–36.4)
60–69 years 16.3 (14.2–18.5)
70–79 years 14.3 (12.3–16.6)
≥80 years 4.8 (3.7–6.2)
Geographic region (n = 1,512)b
Eastern Federal States 19.1 (16.7–21.7)
Western Federal States 80.9 (78.3–83.3)
Underlying chronic disease (n = 1,501) 41.1 (37.8–44.5)
<60 years and underlying chronic disease (n = 694) 30.0 (25.9–34.4)
≥60 years and underlying chronic disease (n = 807) 61.2 (56.4–65.8)
Migration background (n = 1,497) 16.2 (13.8–19.0)




a Weighted data (totals are not weighted)
b Eastern Federal States: Mecklenburg-Vorpommern, Brandenburg, Berlin,
Saxony, Saxony-Anhalt, Thuringia; Western Federal States: Schleswig-Holstein,
Bremen, Hamburg, Lower Saxony, Hesse, Rhineland-Palatinate, Saarland, North
Rhine-Westphalia, Bavaria, Baden-Württemberg
c Low: 9 years or less of school education; Middle: at least 10 years of school
education; High: university entrance diploma
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(95 % CI 47.3–58.8 and 47.4–58.8 for 2012/13 and 2013/
14, respectively). Vaccination coverage increased with
age and was highest in persons aged 70–79 years.
Of participants in Group 1 (people aged 18–59 years
with underlying chronic diseases), 24.1 % were vacci-
nated in 2012/13 and 22.6 % in 2013/14. Overall, vaccin-
ation coverage declined between 2012/13 and 2013/14.
The greatest decrease was observed among people not
belonging to the vaccination target group (aged 18–59
without underlying chronic diseases).
Vaccination status was available for 431 children
(95.8 %), of which 15.1 % (95 % CI 11.8–18.8, crude
without weighting) were vaccinated against seasonal in-
fluenza. Of all sampled children, 6.7 % (95 % CI 4.6–9.5,
crude without weighting) suffered from an underlying
chronic disease and of these, 24.1 % (95 % CI 10.3–43.5,
crude without weighting) were vaccinated during the
2013/14 season. Participants who received a flu shot in
2013/14 were more likely to have at least one child vac-
cinated in their household than unvaccinated partici-
pants (44.3 % vs. 13.4 %, respectively, p <0.001).
Reasons for not being immunized
In all unvaccinated participants (at risk and not at risk), the
most frequently stated reasons for not having received an
influenza vaccination were a perception of being at low risk
for influenza disease (26.7 %, 95 % CI 23.3–30.5), not hav-
ing thought about influenza vaccination yet (21.5 %, 95 %
CI 18.1–25.3) and mistrust of the vaccination (18.3 %, 95 %
CI 15.5–21.5). Moreover, 9.8 % (95 % CI 7.8–12.3) of un-
vaccinated participants opposed vaccination in general
(7.2 % of all participants, 95 % CI 5.7–9.0). Among the vac-
cination opponents, older people rejected vaccination more
frequently than younger people (participants <60 years:
7.8 % vs. participants ≥60 years: 15.9 %, p < 0.05).
Among at-risk participants, the most commonly stated
reasons for not being vaccinated were (Fig. 1) mistrust
of the vaccination (22.3 %), perception of low risk for in-
fluenza disease (21.2 %), and not having thought about
influenza immunization yet (14.9 %). Of all participants,
5.5 % (95 % CI 3.1–9.5) of those ≥60 years and 9.7 %
(95 % CI 6.1–15.1) of the chronically ill (independent of
age) did not know that they belonged to a group for
whom seasonal influenza vaccination is recommended.
Participants who were not at-risk felt that influenza
was not a dangerous disease and considered not getting
vaccinated more often than at-risk participants (31.3 %
vs. 21.2 %, p < 0.05 and 26.0 % vs. 14.9 %, p < 0.05, re-
spectively). Interestingly, at-risk participants reported
mistrust of the vaccination, health issues that deterred
them from vaccination and opposing vaccination in gen-
eral more often than not at-risk participants (22.3 % vs.
15.5 %, p < 0.05, 13.5 % vs. 3.5 %, p < 0.001 and 12.5 %
vs. 7.8 %, p < 0.05, respectively).
Information seeking behavior
Of all participants (at risk and not at risk), 25.5 % (95 %
CI 22.6–28.8) reported a need for further influenza
vaccination-related information. Among at-risk partici-
pants, 22.1 % (95 % CI 18.5–26.1) stated an information
demand. They were particularly interested in informa-
tion on vaccination-related side effects (76.4 %, 95 % CI
67.3–83.6) and potential influenza-associated complica-
tions (61.4 %, 95 % CI 51.4–70.5). At-risk participants
preferred to receive information from their physicians
(67.7 %, 95 % CI 58.0–76.1).
Influenza- and vaccination-related attitudes and knowledge
Among at-risk participants, the perceived probability of
becoming infected with influenza was higher than the fear
of vaccination side-effects (median: 5 vs. 3; both ranges:
1–10). In contrast, the perceived severity of influenza dis-
ease was identical to the perceived severity of possible vac-
cination side-effects (median: 5, range: 1–10 for both
groups). The perceived effectiveness of seasonal influenza
vaccination was higher among at-risk participants than
those not at-risk (median: 6 vs. 5, both ranges: 1–10).
Differences in vaccination- and disease-related knowledge
between unvaccinated and vaccinated at-risk participants
Table 2 Influenza vaccination uptake in 2012/13 and 2013/14
2012/13 % (95 % CI)a 2013/14 % (95 % CI)a
Total 30.2 (27.3–33.4) 26.6 (23.8–29.6)
Sex
Male 29.4 (25.2–34.1) 22.0 (18.5–26.0)
Female 31.0 (26.9–35.3) 30.8 (26.7–35.1)
Age
18–39 years 15.3 (10.8–21.3) 9.9 (6.7–14.6)
40–59 years 23.3 (18.8–28.7) 18.2 (14.1–23.2)
≥60 years 50.0 (45.2–54.8) 49.4 (44.6–54.2)
60–69 years 40.6 (34.1–47.4) 39.4 (32.9–46.3)
70–79 years 58.5 (50.7–66.0) 59.2 (51.4–66.5)
≥80 years 55.7 (42.5–68.1) 53.5 (40.5–66.0)
Underlying chronic disease
Yes 41.5 (36.5–46.7) 40.4 (35.4–45.6)
<60 years 24.1 (17.8–31.9) 22.6 (16.4–30.2)
≥60 years 56.6 (50.3–62.7) 56.3 (50.1–62.3)
No 23.0 (19.5–27.0) 17.4 (14.5–20.8)
<60 years 17.7 (13.9–22.4) 11.0 (8.2–14.6)
≥60 years 40.5 (33.2–48.2) 38.4 (31.3–46.0)
Place of residence
Eastern Federal States 44.4 (37.5–51.5) 38.7 (32.1–45.6)
Western Federal States 27.0 (23.8–30.4) 23.5 (20.6–26.7)
a Weighted data
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are presented in Table 3. Independent of vaccination sta-
tus, 53.8 % (95 % CI 49.4–58.1) of at-risk participants be-
lieved that vaccination could cause an infection. The
results showed that vaccinated at-risk participants agreed
that the vaccination could not cause influenza infection
more often than unvaccinated at-risk participants (58.2 %
vs. 38.5 %, respectively, p <0.001).
Factors associated with vaccination uptake in individuals
aged 18–59 years with underlying chronic diseases
(Group 1) and older adults (Group 2)
Tables 4 and 5 present the results of the univariate and
multivariable logistic regression analyses of factors influ-
encing vaccination uptake in participants in Group 1
and Group 2 for the 2013/14 season. For both risk
groups, influenza vaccination uptake was independently
associated with sex, perceived severity of influenza, and
perceived vaccination effectiveness. In Group 1, vaccin-
ation uptake was negatively associated with perceived se-
verity of vaccination side effects and in Group 2 uptake
was negatively associated with perceived probability of
vaccination side effects. For participants in Group 2, be-
ing advised of the influenza vaccination through phys-
ician consultation in the last six months and having an
underlying chronic disease were further promoters of
vaccination uptake. The interaction term in the final
model for older adults indicated that being female in
addition to an underlying chronic disease influenced
vaccination uptake, showing that women without under-
lying chronic disease were more often vaccinated than
healthy men.
Discussion
Our study aimed to estimate seasonal influenza vaccin-
ation uptake in people aged ≥60 years and in people with
underlying chronic diseases in Germany. Furthermore,
influenza-related attitudes and knowledge, as well as
factors influencing vaccination decision-making were
analyzed. Our results revealed that vaccination coverage
remained suboptimal for at-risk groups in Germany:
Fig. 1 Reasons against seasonal influenza vaccination given by unvaccinated at-risk participants (n = 586), Germany, 2014 (weighted data; multiple
answers were allowed)
Table 3 Influenza- and influenza vaccination-related knowledge among unvaccinated (n = 429) and vaccinated (n = 586) at-risk
participants, Germany 2014
Vaccination status Agreement %
(95 % CI)a
p-value
Coughing or sneezing inside of the elbow can reduce the risk of influenza infection Not vaccinated 68.7 (62.9–73.9) -
Vaccinated 72.4 (66.5–77.7) ≥0.05
Regular hand-washing with soap can reduce the risk of influenza infection Not vaccinated 91.7 (87.7–94.5) -
Vaccinated 93.9 (88.7–96.8) ≥0.05
Vaccination cannot cause influenza infection Not vaccinated 38.5 (33.1–44.3) -
Vaccinated 58.2 (51.5–64.6) <0.01 **
Vaccination protects people in close surroundings Not vaccinated 44.4 (38.7–50.2) -
Vaccinated 55.2 (48.5–61.8) <0.05 *
After immunization or infection with influenza, vaccination in subsequent influenza season is necessary Not vaccinated 74.3 (68.8–79.1) -
Vaccinated 79.7 (73.5–84.8) ≥0.05
a Weighted data
*p <0.05; **p < 0.001
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Only 49 % of older adults and 23 % of chronically ill
people aged 18–59 years were vaccinated in 2013/14.
Our findings on vaccination coverage rates are consist-
ent with results from other European countries [6, 8].
Only the United Kingdom and the Netherlands have
achieved the EU goal of 75 % vaccination coverage for
older adults [8]. The different vaccination rates between
EU countries might be explained by different communi-
cation activities supporting the vaccination recommen-
dations, differences in vaccination systems and funding
schemes, and also in different attitudes related to sea-
sonal influenza vaccination. In England, general practi-
tioners and other providers are encouraged to contact
eligible patients in September and invite them to attend
the clinic for vaccination [19]. However, because study
methodologies differed (telephone survey vs. computer-
ized immunization registries and clinical records), such
differences in vaccination uptake must be interpreted
with caution.
Compared to previous seasons, influenza vaccination
uptake in at-risk groups decreased slightly in Germany, al-
though this result was not statistically significant. Results
of the nationwide survey German Health Update showed
a vaccination coverage of 54 % in people aged ≥60 years in
2010/11 and 53 % in 2011/12. For people aged 18–59
years with underlying chronic diseases, vaccination uptake
was 30 % in 2010/11 and 25 % in 2011/12 [20]. A decrease
in influenza vaccination coverage in at-risk people has also
been observed in other European countries after the 2009/
10 pandemic [21–24]. A Spanish study found a decrease
in vaccination coverage in older adults from 69 % in 2009/
10 to 57 % in 2012/13 [25]. However, in countries such as
England, no decrease in coverage was observed [26]. In
our study, the strongest decrease in vaccination coverage
Table 4 Factors associated with influenza vaccination uptake in people aged 18–59 years with underlying chronic diseases,
Germany, 2013/14 influenza season
Vaccination coverage %a, b Univariate OR
(95 % CI)a, b
Multivariable OR
(95 % CI)a, c
Sex
Female 27.4 1.80 (0.81–4.02) 4.07 (1.50–11.03)
Male 17.3 Ref. Ref.
Place of residence
Eastern Federal States 33.2 2.18 (0.92–5.17) NS
Western Federal States 18.6 Ref.
Age
18–39 years 18.4 NS NS
40–59 years 24.7
Education level
Low 24.2 NS NS
Middle 24.6
High 19.1
Vaccination cannot cause influenza infection
Agreed 27.9 1.82 (0.82–4.08) NS
Disagreed 17.5 Ref.
Coughing or sneezing inside of the elbow can reduce the risk of influenza infection
Agreed 26.0 2.18 (0.95–4.97) NS
Disagreed 13.9 Ref.
Perceived probability of getting infected with influenza when not immunized − 1.28 (1.07–1.53) NS
Perceived severity of influenza when not immunized − 1.58 (1.18–2.13) 1.40 (1.07–1.85)
Perceived vaccination effectiveness − 1.39 (1.19–1.62) 1.25 (1.03–1.52)
Perceived severity of side effects following vaccination − 0.75 (0.63–0.89) 0.71 (0.57–0.88)
Perceived probability of severe side effects following vaccination − 0.70 (0.55–0.89) NS
Other nonsignificant variables in univariate analysis (p > 0.1) were: migration, being advised of the influenza vaccine through physician consultation in the last
6 months, and items focusing on influenza- and vaccine-related knowledge
aWeighted data; bIncluded participants with information on relevant item; cIncluded n = 166 participants with complete information on all items; NS not
significant, Ref. reference category
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Table 5 Factors associated with influenza vaccination uptake in people aged ≥60 years, Germany, 2013/14 influenza season
Vaccination coverage %a, b Univariate OR
(95 % CI)a, b
Multivariable OR
(95 % CI)a, c
Sex
Female 53.4 1.43 (0.97–2.11) –
Male 44.4 Ref.
Underlying chronic disease
Yes 56.3 2.07 (1.39–3.09) –
No 38.4 Ref.
Sex and chronic diseasee
Male and no chronic disease 28.2 – Ref.
Male and chronic disease 54.1 2.10 (0.81–5.43)
Female and no chronic disease 46.6 4.80 (1.72–13.43)
Female and chronic disease 58.1 2.13 (0.73–6.19)
Place of residence
Eastern Federal States 62.8 1.97 (1.26–3.10) NS
Western Federal States 46.1 Ref.
Age
60–69 years 39.4 Ref. Ref.
70–79 years 59.2 2.23 (1.46–3.40) 2.67 (1.42–5.03)
≥80 years 53.5 1.77 (0.97–3.20) 1.89 (0.73–4.89)
Education level
Low 51.9 Ref. NS
Middle 43.5 0.71 (0.47–1.08)
High 43.8 0.72 (0.49–1.06)
Being advised of the influenza vaccination through physician consultation in the last 6 months
Yes 63.0 2.87 (1.89–4.37) 2.63 (1.44–4.84)
No 37.2 Ref. Ref.
Vaccination cannot cause influenza infection
Agreed 62.0 2.62 (1.77–3.90) NS
Disagreed 38.4 Ref.
Vaccination protects people in close surroundings
Agreed 54.9 1.57 (1.06–2.33) NS
Disagreed 43.6 Ref.
After immunization or infection with influenza, vaccination in subsequent influenza season is necessary
Agreed 52.5 1.64 (1.02–2.63) NS
Disagreed 40.3 Ref.
Perceived probability of getting infected with influenza when not immunized − 1.44 (1.28–1.61) NS
Perceived severity of influenza when not immunized − 1.56 (1.41–1.71) 1.31 (1.13–1.52)
Perceived vaccination effectiveness − 1.59 (1.45–1.74) 1.42 (1.24–1.62)
Perceived severity of side effects following vaccination − 0.83 (0.76–0.90) NS
Perceived probability of severe side effects following vaccination − 0.77 (0.70–0.85) 0.69 (0.61–0.80)
Other nonsignificant variables in univariate analysis (p > 0.1) were: migration and items focusing on influenza- and vaccination-related knowledge
aWeighted data; bIncluded participants with information on relevant item; cIncluded n = 550 participants with complete information on all items; NS not
significant; Ref. reference category; ep-value for interaction between sex*chronic disease: 0.012
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was identified in individuals who did not belong to a vac-
cination target group: Vaccination uptake in healthy indi-
viduals aged 18–59 years declined from 18 % in 2012/13
to 11 % in 2013/14. Perceived low vaccination effective-
ness, a perception of being at low risk for influenza dis-
ease, the fact that many people indicated that they had not
yet thought about influenza vaccination, higher skepticism
about vaccination after the pandemic season, and an initial
influenza vaccination shortage in the 2013/14 season may
have influenced their vaccination decision-making process
more strongly than people who belonged to an at-risk
group [27, 28, 14].
In at-risk people, the most commonly stated reasons
against having received a flu shot were mistrust of the vac-
cination, a perception of being at low risk for influenza dis-
ease, and the fact that they had not yet thought about
vaccination. These results were consistent with the findings
of studies from other industrialized countries [29–35]. A
Canadian study found that the most commonly reported
reason to opt out of influenza vaccination in people
aged ≥60 years and people with chronic medical condi-
tions were low perceived susceptibility to influenza or
low perceived severity of the infection, as well as a lack
of interest, and lack of time or information [29]. An-
other study found that in Germany, forgetfulness was a
primary barrier to influenza vaccination [30].
It is concerning that almost 10 % of all unvaccinated
participants stated that they were opposed to vaccination
in general (7 % of all participants). This was particularly
true for older adults. In Germany, it has been estimated
that 3–5 % of the population rejects immunizations in
general [36] and one study found that 31 % had some
prejudice against particular vaccines [37]. Results from
another German study showed that overall, older adults
perceived vaccinations as less important than younger
people [35]. However, because our study focused on in-
fluenza vaccination, we could not rule out that some
participants may have mistakenly referred the question
to the influenza vaccination itself instead of vaccinations
in general. Therefore, this result must be interpreted
with caution.
With regard to factors associated with influenza vaccin-
ation uptake in older adults and people aged 18–59 years
with chronic diseases, our results were similar for both tar-
get groups. In agreement with other studies, our analysis
suggested that age and health conditions as well as percep-
tions relating to the disease and the vaccination were pre-
dictors of influenza vaccination status [32, 38–43].
We were not able to observe any association between
influenza- und vaccination-related knowledge and vaccin-
ation uptake. A Canadian study suggested that knowledge
played a smaller role in the vaccination decision-making
process than beliefs concerning risk perception and
vaccination effectiveness [33]. Betsch et al. found that the
perceived risks of influenza disease and vaccination
were key drivers of vaccination intention rather than
cognitive risk estimation [44, 45]. Finally, a similar find-
ing was demonstrated by Brewer et al. [46] who sup-
ported the assertion that risk was the main predictor of
vaccination behavior.
Our analyses revealed a potential association between
vaccination uptake and being advised about the influ-
enza vaccine through consultation with a physician.
However, it is interesting that this was only observed
among older adults. Other studies have also showed that
the physician recommendation is a crucial facilitator in
the vaccination decision-making process but it remains
unclear whether the patients’ age might play an addition
role [47, 48, 32, 42]. The fact that some participants did
not know that influenza vaccination is recommended for
them and mentioned physicians as the desired source of
influenza- and vaccination-related information under-
lines the important role of physicians in obtaining high
vaccination coverage.
Our study has some potential limitations: (i) The re-
sponse and cooperation rates as defined by AAPOR [15]
were low at 16.2 and 28.7 %, respectively. However, be-
cause of our study design (using mobile and landline
telephones and a complex weighting procedure), it can
be assumed that data quality is good overall in terms of
generalizability to the German population. However, we
cannot rule out some degree of selection bias. (ii) Infor-
mation on chronic underlying diseases and vaccination
uptake were self-reported and could therefore be subject
to misclassification. While a recently published study
suggested an overestimation for self-reported seasonal
influenza vaccination rates compared to vaccination
registries [25] other studies found an adequate degree of
reliability [49, 50]. Therefore, it can be assumed that vac-
cination coverage rates in our study population are ra-
ther overestimated. (iii) The sample was limited to the
German-speaking population as the interviews were car-
ried out in German. People who were not able to under-
stand or speak German were therefore not represented
in the study population, which might have introduced
selection bias.
Conclusion
In conclusion, our study results indicated suboptimal
seasonal influenza vaccination coverage in Germany for
people aged ≥60 years and those with underlying chronic
diseases. Compared with previous seasons, vaccination
coverage in at-risk groups remained stable, while cover-
age in the healthy population decreased considerably.
While knowledge on disease- or vaccination-related is-
sues did not influence vaccination decisions, perceptions
of the disease severity and vaccination effectiveness as
well as perceived likelihood and severity of vaccination
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side effects were key drivers for increased vaccination up-
take. Additionally, many at-risk people had not thought
about receiving a flu shot. Implementing reminder sys-
tems could therefore be helpful [51, 52]. As personal
beliefs are crucial in the vaccination decision-making
process, tailored communication strategies should focus
on improving understanding about and perception of per-
sonal risks concerning the disease and the vaccination in
the vaccination target groups.
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